TRPV2: A Cancer Biomarker and Potential Therapeutic Target

TRPV2: A Cancer Biomarker and Potential Therapeutic Target

<p>The Transient Receptor Potential Vanilloid type-2 (TRPV2) channel exhibits oncogenicity in different types of cancers. TRPV2 is implicated in signaling pathways that mediate cell survival, proliferation, and metastasis. In leukemia and bladder cancer, the oncogenic activity of TRPV2 was lin...

Full description

Saved in:
Bibliographic Details
Main Author: Kodappully S. Siveen (4246150) (author)
Other Authors: Parveen B. Nizamuddin (14590613) (author), Shahab Uddin (14150949) (author), Mohamed Al-Thani (14590614) (author), Michael Paul Frenneaux (14590617) (author), Ibrahim A. Janahi (14070765) (author), Martin Steinhoff (5340194) (author), Fouad Azizi (14152740) (author)
Published: 2020
Subjects:
Biomedical and clinical sciences
Clinical sciences
Oncology and carcinogenesis
Precision medicine
Cancer biomarkers
Tumor cell growth
Oncogenicity
Cancer progression
Therapeutic targets
Genetic alterations
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items